Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway

Dairmuid M. Moran, M. Adrian Mattocks, Paul A. Cahill, Leonidas G. Koniaris, Iain H. McKillop

Research output: Contribution to journalArticle

41 Scopus citations

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates diverse cell functions including proliferation and differentiation. Within the liver IL-6 signaling plays a central role during normal hepatic growth and regeneration yet can inhibit the proliferation of hepatocellular carcinoma (HCC) cells. The aim of the current study was to identify underlying mechanisms whereby IL-6 induces cell-cycle arrest in HCC cells. These studies demonstrate that IL-6 inhibits cell-cycle progression at the G0/G1 interface through inhibition of cyclin-dependent kinase (cdk) 2 and cdk4 activity in the absence of changes in total cyclin (A, D1, D3, and E) or cdk (cdk2, 4, and cdc2 p34) expression. Inhibition of signal transduction pathways associated with IL-6 receptor activation demonstrates that IL-6-dependent inhibition of G0-G1 progression occurs via Janus tyrosine kinase-signal transducers and activators of transcription-3 (Jak-STAT3)-dependent induction of p21waf1/cip1 and is independent of ERK-MAPK signaling. These data demonstrate that, while IL-6 plays a central role in hepatocyte priming and proliferation in vivo, the pronounced inhibition of proliferation observed in HCC cells occurs due to IL-6-STAT3-dependent regulation of cdk2/cdk4 activity and p21waf1/cip1 expression.

Original languageEnglish (US)
Pages (from-to)23-33
Number of pages11
JournalJournal of Surgical Research
Volume147
Issue number1
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Keywords

  • cyclin-dependent kinases
  • growth arrest
  • hepatocellular carcinoma
  • interleukin-6
  • mitogenesis

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Interleukin-6 Mediates G<sub>0</sub>/G<sub>1</sub> Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway'. Together they form a unique fingerprint.

  • Cite this